Daily Archives: May 11, 2012

Updated: FDA committee recommends Truvada’s approval as PrEP

By on .

The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee recommended Thursday that the supplemental application for Gilead Sciences’ HIV drug Truvada (a combination of emtricitabine plus tenofovir, or TDF-FTC) as pre-exposure prophylaxis (PrEP) be approved for high-risk, HIV-negative individuals to reduce the risk of sexually acquired HIV infection. The panel of medical experts, […]

Accordia Foundation Measures Impact of Capacity-Building Programs

By on .

Global health advocates discussed the findings of an ongoing study measuring the effectiveness of infectious disease training programs at a recent briefing hosted by The Accordia Global Health Foundation. The Integrated Infectious Disease Capacity-Building Evaluation (IDCAP) is a three-year program funded by the Bill & Melinda Gates Foundation with the goal of evaluating training programs […]